[1] 李胜前, 王洋, 刘福, 等. 舒眠胶囊治疗肝郁伤神型失眠症的临床研究[J]. 中国药业, 2014, 23: 6-7. [2] Banks S, Dinges D. Behavioral and physiological consequences of sleep restriction[J]. J Clin Sleep Med: official publication of the American Academy of Sleep Medicine, 2007, 3: 519-528. [3] Owen JE, Veasey SC. Impact of sleep disturbances on neurodegeneration: insight from studies in animal models[J]. Neurobiol Dis, 2020, 139: 104820. doi: 10.1016/j.nbd.2020.104820. [4] Salim S. Oxidative stress and the central nervous system[J]. J Pharmacol Exp Ther, 2017, 360: 201-205. [5] Li Y, Cheng Y, Zhang Y, et al. Shumian capsule improves the sleep disorder and mental symptoms through melatonin receptors in sleep-deprived mice[J].Front Pharmacol, 2022, 13: 925828. doi: 10.3389/fphar.2022.925828. [6] 聂雨杉, 彭潇, 马雪, 等. UHPLC-Q-Orbitrap-HRMS法分析舒眠胶囊化学成分[J]. 中成药, 2023, 45: 127-134. [7] 谭云龙,孙晖,孙文军, 等. 酸枣仁化学成分及其药理作用研究进展[J]. 时珍国医国药, 2024,25:186-188. [8] Rémi J, Pollmächer T, Spiegelhalder K, et al. Sleep-related disorders in neurology and psychiatry[J]. Deutsch Arztebl Int, 2019, 116: 681-688. [9] Buysse D, Bate G, Kirkpatrick P. Fresh from the pipeline: Ramelteon[J]. Nat Rev Drug Discov, 2005, 4: 881-882. [10] Imamura S, Tabuchi M, Oizumi H, et al. Yokukansankachimpihange, a traditional Japanese (Kampo) medicine, enhances the adaptation to circadian rhythm disruption by increasing endogenous melatonin levels[J]. J Pharmacol Sci, 2020, 144: 129-138. [11] Wang M, Ramos B, Paspalas C, et al. Alpha2A-adrenoceptors strengthen working memory networks by inhibiting cAMP-HCN channel signaling in prefrontal cortex[J]. Cell, 2007, 12: 397-410. [12] Xiao D, Deng P, Rojanathammanee L, et al. Noradrener-gic depression of neuronal excitability in the entorhinal cortex via activation of TREK-2 K+ channels[J]. J Biol Chem, 2009, 284: 10980-10991. [13] Robbins T, Arnsten A. The neuropsychopharmacology of fronto-executive function: monoaminergic modulation[J]. Annu Rev Neurosci, 2009, 32: 267-287. |